IFP Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.5K	Sell	7,655 -22,700	-75%	-$87.7K	﹤0.01%	2687
2025 Q4	$124K	Buy	30,355 +20,000	+193%	+$99.1K	﹤0.01%	1661
2025 Q3	$50.5K	Buy	10,355 +4,650	+82%	+$24.4K	﹤0.01%	2069
2025 Q2	$28.9K	Sell	5,705 -10,103	-64%	-$49.6K	﹤0.01%	2345
2025 Q1	$83.6K	Buy	15,808 +3,977	+34%	+$29K	﹤0.01%	1625
2024 Q4	$80K	Buy	11,831 +7,455	+170%	+$50.1K	﹤0.01%	1583
2024 Q3	$28.8K	Buy	4,376 +2,875	+192%	+$20.6K	﹤0.01%	1987
2024 Q2	$11.3K	Buy	1,501 +500	+50%	+$4.36K	﹤0.01%	2303
2024 Q1	$9.98K	Buy	1,001 +1,000	+100,000%	+$11.1K	﹤0.01%	2234
2023 Q4	$10	Hold	1	–	–	﹤0.01%	3021
2023 Q3	$8	Buy	+1	New	+$10	﹤0.01%	3274